Dabigatran versus Warfarin in Patients with Atrial Fibrillation von Connolly, Stuart J, Ezekowitz, Michael D, Yusuf, Salim, Eikelboom, John, Oldgren, Jonas, Parekh, Amit, Pogue, Janice, Reilly, Paul A, Themeles, Ellison, Varrone, Jeanne, Wang, Susan, Alings, Marco, Xavier, Denis, Zhu, Jun, Diaz, Rafael, Lewis, Basil S, Darius, Harald, Diener, Hans-Christoph, Joyner, Campbell D, Wallentin, Lars

Volltext

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events von Yusuf, Salim, Teo, Koon K, Pogue, Janice, Dyal, Leanne, Copland, Ingrid, Schumacher, Helmut, Dagenais, Gilles, Sleight, Peter, Anderson, Craig

Volltext

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controll... von Yusuf, S, Teo, K, Anderson, C, Pogue, J, Dyal, L, Copland, I, Schumacher, H, Dagenais, G, Sleight, P

Volltext

Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome von Bittner, Vera A., Szarek, Michael, Aylward, Philip E., Bhatt, Deepak L., Diaz, Rafael, Edelberg, Jay M., Fras, Zlatko, Goodman, Shaun G., Halvorsen, Sigrun, Hanotin, Corinne, Harrington, Robert A., Jukema, J. Wouter, Loizeau, Virginie, Moriarty, Patrick M., Moryusef, Angèle, Pordy, Robert, Roe, Matthew T., Sinnaeve, Peter, Tsimikas, Sotirios, Vogel, Robert, White, Harvey D., Zahger, Doron, Zeiher, Andreas M., Steg, Ph. Gabriel, Schwartz, Gregory G.

Volltext

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial von Keech, A, Simes, R J, Barter, P, Best, J, Scott, R, Taskinen, M R, Forder, P, Pillai, A, Davis, T, Glasziou, P, Drury, P, Kesäniemi, Y A, Sullivan, D, Hunt, D, Colman, P, d'Emden, M, Whiting, M, Ehnholm, C, Laakso, M

Volltext

Diet and Kidney Disease in High-Risk Individuals With Type 2 Diabetes Mellitus von Dunkler, Daniela, Dehghan, Mahshid, Teo, Koon K, Heinze, Georg, Gao, Peggy, Kohl, Maria, Clase, Catherine M, Mann, Johannes F. E, Yusuf, Salim, Oberbauer, Rainer

Volltext

Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial von Jukema, J Wouter, Szarek, Michael, Zijlstra, Laurien E, de Silva, H Asita, Bhatt, Deepak L, Bittner, Vera A, Diaz, Rafael, Edelberg, Jay M, Goodman, Shaun G, Hanotin, Corinne, Harrington, Robert A, Karpov, Yuri, Moryusef, Angèle, Pordy, Robert, Prieto, Juan C, Roe, Matthew T, White, Harvey D, Zeiher, Andreas M, Schwartz, Gregory G, Steg, P Gabriel

Volltext

Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment: The FIELD Study von Ting, Ru-Dee, Keech, Anthony C, Drury, Paul L, Donoghoe, Mark W, Hedley, John, Jenkins, Alicia J, Davis, Timothy M.E, Lehto, Seppo, Celermajer, David, Simes, R. John, Rajamani, Kushwin, Stanton, Kim

Volltext

Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial von Szarek, Michael, White, Harvey D, Schwartz, Gregory G, Alings, Marco, Bhatt, Deepak L, Bittner, Vera A, Chiang, Chern-En, Diaz, Rafael, Edelberg, Jay M, Goodman, Shaun G, Hanotin, Corinne, Harrington, Robert A, Jukema, J Wouter, Kimura, Takeshi, Kiss, Robert Gabor, Lecorps, Guillaume, Mahaffey, Kenneth W, Moryusef, Angèle, Pordy, Robert, Roe, Matthew T, Tricoci, Pierluigi, Xavier, Denis, Zeiher, Andreas M, Steg, Ph Gabriel

Volltext

Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery von Goodman, Shaun G., Aylward, Philip E., Szarek, Michael, Chumburidze, Vakhtang, Bhatt, Deepak L., Bittner, Vera A., Diaz, Rafael, Edelberg, Jay M., Hanotin, Corinne, Harrington, Robert A., Jukema, J. Wouter, Kedev, Sasko, Letierce, Alexia, Moryusef, Angele, Pordy, Robert, Ramos López, Gabriel Arturo, Roe, Matthew T., Viigimaa, Margus, White, Harvey D., Zeiher, Andreas M., Steg, Ph. Gabriel, Schwartz, Gregory G.

Volltext

Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acu... von Roe, Matthew T., Li, Qian H., Bhatt, Deepak L., Bittner, Vera A., Diaz, Rafael, Goodman, Shaun G., Harrington, Robert A., Jukema, J. Wouter, Lopez-Jaramillo, Patricio, Lopes, Renato D., Louie, Michael J., Moriarty, Patrick M., Szarek, Michael, Vogel, Robert, White, Harvey D., Zeiher, Andreas M., Baccara-Dinet, Marie T., Steg, Ph Gabriel, Schwartz, Gregory G.

Volltext

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome von Schwartz, Gregory G., Steg, P. Gabriel, Szarek, Michael, Bhatt, Deepak L., Bittner, Vera A., Diaz, Rafael, Edelberg, Jay M., Goodman, Shaun G., Hanotin, Corinne, Harrington, Robert A., Jukema, J. Wouter, Lecorps, Guillaume, Mahaffey, Kenneth W., Moryusef, Angèle, Pordy, Robert, Quintero, Kirby, Roe, Matthew T., Sasiela, William J., Tamby, Jean-François, Tricoci, Pierluigi, White, Harvey D., Zeiher, Andreas M.

Volltext

Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial von Szarek, Michael, Steg, Ph. Gabriel, DiCenso, Dina, Bhatt, Deepak L., Bittner, Vera A., Budaj, Andrzej, Diaz, Rafael, Goodman, Shaun G., Gotcheva, Nina, Jukema, J. Wouter, Pordy, Robert, Roe, Matthew T., Sourdille, Timothée, White, Harvey D., Xavier, Denis, Zeiher, Andreas M., Schwartz, Gregory G.

Volltext

Risk categorization using New American College of Cardiology/American Heart Association guidelines for cholesterol management and its relation to alirocumab treatment following acu... von Steg, PG, Yong, H, Ray, KK, Chaitman, B, Rosenson, R, Dombrowski, K, Ducrocq, G, Endsley, P, Marcus, J, Pereira, SB, Sassone, SA, Paterlini, GA, Carnero, GS, Guzman, PN, Nani, S, Blumberg, EDS, Liberman, A, Raffel, O, Berger, R, Faes, D, Striekwold, H, Barbato, E, Botelho, RV, Saporito, W, Benov, HO, Morisset, A, Nigro, F, Prieto, JC, Zheng, Y, Zhou, Y, Vallejo, GS, Bonfanti, AJC, Parada, JC, Persic, V, Zdravko, B, Krstulovic, SM, Machova, V, Frost, L, Nielsen, PK, Leclercq, F, Lominadze, Z, Appel, K-F, Werner, N, Sionis, D, Turi, T, Kumbla, M, Sinha, D, Pothineni, RB, Manakshe, GV, Sethi, S, Shechter, M, Hussein, O, De Luca, G, Violini, R, Hata, Y, Mano, T, Ueda, Y, Fanghanel Salmon, G, Brueren, BRG, Wilkins, G, Hurtig, U, Rogelio, G, Pawlowicz, L, Bednarski, J, Dulak, E, Sudnik, W, Apostolovic, SR, Dukat, A, Basson, MMDV, Ebrahim, IO, Cequier Fillat, AR, Garcia-Dorado, D, Romeo, S, Fang, C-Y, Wongpraparut, N, Kushnir, M, Karpenko, Y, Bagriy, A, Kadr, H, Harris, B, Haddad, T, Koren, M, Kobayashi, J, Yazdani, S, Kinzfogl, G, El Shahawy, M, Hodes, Z, Knutson, T, Joshi, P, Farrar, M, Rubenstein, H, Hunter, J, Wozniak, J, Quintero, K, Bougon, N, Agnetti, V, Berthou, C, Normand, M, Cotruta, R, Morrello, C

Volltext

Cardiopulmonary resuscitation in a district general hospital: increased success over 7 years von Thomas, R D, Waites, J H, Hubbard, W N, Wicks, M

Volltext

Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial von Steg, PG, Schwartz, GG, Dilic, M, Alings, M, Correa Flores, RM, De Silva, HA, Hagstrom, E, Armaganijan, L, Leonardi, S, Mathews, R, Bordonava, AP, Cartasegna, LR, Ahuad Guerrero, RA, Rogers, JF, Raffel, O, Coverdale, SGM, Weidinger, F, Wollaert, B, Midzic, Z, Muslibegovic, A, Kalil, R, De Santos, MON, Neuenschwander, F, Vidotti, MH, Lazov, PV, Bourgeois, R, Leung, R, Vuurmans, T, Araneda, G, Fernandez, M, Li, J, Lin, J, Zhang, Z, Zheng, Z, Guo, Y, Silva, SIB, Rokyta, R, Lomholdt, JD, Cottin, Y, Paganelli, F, Schellenberg, D, Muenzel, T, Heidenreich, L, Killat, H, Annam, S, Oomman, A, Chopra, VK, Hussein, O, Novo, S, De Cesare, NB, Nishibe, A, Kim, C, Sime, I, Sakalyte, G, Ong, TK, Bayram Llamas, EA, Nijmeijer, R, Dulak, E, Mendonca, C, Bengus, CM, Kobalava, Z, Barbarash, OL, Yakushin, S, Sotnikova, T, Povzun, A, Ilic, S, Majercak, I, Kamensky, G, Lipar, L, Bayat, J, Bodi Peris, V, Tunon Fernandez, J, Luis Zamorano, J, Rajapaksha, A, Lai, W-T, Bagriy, A, Storey, R, Sharman, D, Wiseman, A, Puri, S, Kumar, P, East, C, Akhter, F, D'Urso, M, El-Ahdab, F, Chandna, H, Bortnick, A, Panchal, V, Nowins, R, Hodes, Z, Raisinghani, A, O'Donnell, PJ, Banuru, S, Lupovitch, S, Spriggs, D, Barrucco, R, Sporn, D, Gibson, P, Al Joundi, T, Ball, E

Volltext

Effect of alirocumab on mortality after acute coronary syndromes. An analysis of the ODYSSEY OUTCOMES randomized clinical trial von Hanotin, C, Lecorps, G, Parkhomenko, A, White, HD, Sinnaeve, P, Kim, S-H, Ramos Lopez, GA, Fras, Z, Bahit, MC, Brennan, JM, Moreira, HG, Vallejos, JA, Patocchi, CA, Saavedra, SS, Waites, JH, Rogers, JF, Oqueli Flores, RE, Starmer, G, Weidinger, F, Castadot, M, Midzic, Z, Muslibegovic, A, Feitosa, GS, Markov, DT, Pearce, S, Thao, H, Raffo, CA, Nahuelpan, L, Cui, L, Zhang, X, Huang, L, Feng, Y, Qu, B, Larsen, J, Davidsen, F, Ferrari, E, Leclercq, F, Clerc, J, Lefevre, T, Dorsel, T, Zirlik, A, Yan, BPY, Katona, A, Horvath, I, Abhyanakar, AD, Kahali, D, Grewal, JS, Palimkar, P, Lotan, C, Fuchs, S, Higashikata, T, Shimizu, M, Nishibe, A, Mintale, I, Lozance, N, Bos, RJ, Groutars, RGEJ, Liem, AAH, Hersbach, FMRJ, Davidson, L, Tomala, T, Calderon Ticona, JR, Vargas Gonzales, RJ, Staneta, P, Stasiewski, A, Matei, AV, Gurevich, V, Shalaev, S, Chumakova, G, Khasanov, N, Ong, HY, Olexa, P, Senaratne, V, Nicol, P, Tsai, W-C, Myshanych, H, Kopytsya, M, Storey, R, Simaitis, A, Vardi, G, Cheng, S-C, Forgosh, L, Gillespie, E, Suh, D, Arif, I, Moran, J, Leimbach, W, Izzo, M, Mclaurin, B, Jafar, Z, Galski, T, Banuru, S, Ahmed, H, Alsweiler, C, Agnetti, V, Mthombeni, B, Okan, B, Scemama, M, Gouet, V, Zobouyan, I

Volltext

Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481] von Scott, R, Best, J, Forder, P, Taskinen, M-R, Simes, J, Barter, P, Keech, A

Volltext

The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783...

Volltext

Titan from Cassini-Huygens von Brown, Robert H, Lebreton, Jean P, Waite, J. H

Volltext